Treatment of HCV infection in Poland at the beginning of the interferon-free era-the EpiTer-2 study-Reference-Cited by-同舟云学术

Treatment of HCV infection in Poland at the beginning of the interferon-free era-the EpiTer-2 study

Published:2018-02-06 Issue:6 Volume:25 Page:661-669
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Flisiak R.¹^ORCID,Zarębska-Michaluk D.²,Janczewska E.³,Staniaszek A.⁴,Gietka A.⁴,Mazur W.⁵,Tudrujek M.⁶,Tomasiewicz K.⁶,Belica-Wdowik T.⁷,Baka-Ćwierz B.⁷,Dybowska D.⁸,Halota W.⁸,Lorenc B.⁹,Sitko M.¹⁰,Garlicki A.¹⁰,Berak H.¹¹,Horban A.¹¹,Orłowska I.¹²,Simon K.¹²,Socha Ł.¹³,Wawrzynowicz-Syczewska M.¹³,Jaroszewicz J.¹⁴,Deroń Z.¹⁵,Czauż-Andrzejuk A.¹,Citko J.¹⁶,Krygier R.¹⁷,Piekarska A.¹⁸,Laurans Ł.¹³¹⁹,Dobracki W.²⁰,Białkowska J.²¹,Tronina O.²²,Pawłowska M.⁸

Affiliation:

1. Department of Infectious Diseases and Hepatology; Medical University of Białystok; Białystok Poland

2. Department of Infectious Diseases; Voivodship Hospital and Jan Kochanowski University; Kielce Poland

3. Hepatology Outpatient Clinic; ID Clinic; Mysłowice Poland

4. Department of Internal Medicine and Hepatology; Central Clinical Hospital of the Ministry of Internal Affairs and Administration; Warsaw Poland

5. Clinical Department of Infectious Diseases; Specialist Hospital in Chorzów; Medical University of Silesia; Katowice Poland

6. Department of Infectious Diseases and Hepatology; Medical University of Lublin; Lublin Poland

7. Regional Center for Diagnosis and Treatment of Viral Hepatitis and Hepatology; John Paul II Hospital; Kraków Poland

8. Department of Infectious Diseases and Hepatology; Faculty of Medicine; Collegium Medicum Bydgoszcz; Nicolaus Copernicus University Toruń; Toruń Poland

9. Pomeranian Center of Infectious Diseases; Department of Infectious Diseases; Medical University of Gdańsk; Gdańsk Poland

10. Department of Infectious and Tropical Diseases; Jagiellonian University Collegium Medicum; Kraków Poland

11. Hospital for Infectious Diseases in Warsaw; Medical University in Warsaw; Warsaw Poland

12. Department of Infectious Diseases and Hepatology; Wrocław Medical University; Warsaw Poland

13. Department of Infectious Diseases; Hepatology and Liver Transplantation; Pomeranian Medical University; Szczecin Poland

14. Department of Infectious Diseases; Medical University of Silesia in Katowice; Bytom Poland

15. Ward of Infectious Diseases and Hepatology; Biegański Regional Specialist Hospital; Łódź Poland

16. Medical Practice of Infections; Regional Hospital; Olsztyn Poland

17. Infectious Diseases and Hepatology Outpatient Clinic NZOZ “Gemini”; Żychlin Poland

18. Department of Infectious Diseases and Hepatology; Medical University of Łódź; Łódź Poland

19. Multidisciplinary Regional Hospital in Gorzów Wielkopolski; Gorzów Wielkopolski Poland

20. MED-FIX Medical Center; Wrocław Poland

21. Department of Infectious and Liver Diseases; Medical University of Łódź; Łódź Poland

22. Department of Transplantation Medicine; Nephrology, and Internal Diseases; Medical University of Warsaw; Warsaw Poland

Funder

Polskie Towarzystwo Epidemiologów i Lekarzy Chorób Zakaźnych

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12861/fullpdf

Reference21 articles.

1. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study;European Union HCV Collaborators;Lancet Gastroenterol Hepatol,2017

2. Prevalence and risk factors of HCV infection in Poland;Flisiak;Eur J Gastroenterol Hepatol,2011

3. The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2;Hatzakis;J Viral Hepat,2015

4. Current drugs in early development for treating hepatitis C virus- related hepatic fibrosis;Jaroszewicz;Expert Opin Investig Drugs,2015

5. Real-world effectiveness and safety of Ombitasvir/Paritaprevir/Ritonavir±Dasabuvir±Ribavirin in hepatitis C: AMBER study;Flisiak;Aliment Pharmacol Ther,2016

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals;Expert Opinion on Pharmacotherapy;2024-05-02

2. Drug Resistance to HCV in Direct-Acting Antiviral Treatments;Viral Hepatitis Journal;2023-12-26

3. Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era;World Journal of Gastroenterology;2023-04-07

4. Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2023;Clinical and Experimental Hepatology;2023

5. HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons;Viruses;2022-02-26